Načítá se...

NHLBI’s Program for VAD Therapy for Moderately Advanced Heart Failure: The REVIVE-IT Pilot Trial

BACKGROUND: VADs are used to bridge heart failure patients to transplantation, to allow their own hearts to recover, or as permanent (“destination”) therapy. To date, the use of VADs has been limited to late-stage heart failure patients because of the associated device risks. In 2008, an NHLBI worki...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Baldwin, J. Timothy, Mann, Douglas L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2994073/
https://ncbi.nlm.nih.gov/pubmed/21055648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cardfail.2010.06.414
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!